BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30297301)

  • 21. How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.
    Hersch J; McGeechan K; Barratt A; Jansen J; Irwig L; Jacklyn G; Houssami N; Dhillon H; McCaffery K
    BMJ Open; 2017 Oct; 7(10):e016246. PubMed ID: 28988168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are Providers Prepared to Engage Younger Women in Shared Decision-Making for Mammography?
    Martinez KA; Deshpande A; Ruff AL; Bolen SD; Teng K; Rothberg MB
    J Womens Health (Larchmt); 2018 Jan; 27(1):24-31. PubMed ID: 28657820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does a decision aid improve informed choice in mammography screening? Study protocol for a randomized controlled trial.
    Reder M; Kolip P
    BMC Womens Health; 2015 Jul; 15():53. PubMed ID: 26198675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Danish Women Want to Participate in a Hypothetical Breast Cancer Screening with Harms and No Reduction in Mortality: A Cross-Sectional Survey.
    Røssell EL; Bo A; Grønborg TK; Kristiansen IS; Borgquist S; Scherer LD; Støvring H
    Med Decis Making; 2023 May; 43(4):403-416. PubMed ID: 36734154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammography screening. Benefits, harms, and informed choice.
    Jørgensen KJ
    Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.
    Driedger SM; Annable G; Brouwers M; Turner D; Maier R
    BMC Cancer; 2017 Sep; 17(1):647. PubMed ID: 28903742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Content of official addressed to women informative documents about breast cancer screening in Spain].
    Ballesteros-Peña S; Gavilán-Moral E
    Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30361472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent controversies over mammography screening].
    Hinneburg I
    Med Monatsschr Pharm; 2014 Aug; 37(8):280-3. PubMed ID: 25158376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of Informed Consent in Mammography Screening-The Polish Experience.
    Zagaja A; Bogusz R; Sak J; Wiechetek M; Pawlikowski J
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women's participation in breast cancer screening in France--an ethical approach.
    Moutel G; Duchange N; Darquy S; de Montgolfier S; Papin-Lefebvre F; Jullian O; Viguier J; Sancho-Garnier H;
    BMC Med Ethics; 2014 Aug; 15():64. PubMed ID: 25127662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Informed consent for mammography screening: modelling the risks and benefits for American women.
    Marshall T
    Health Expect; 2005 Dec; 8(4):295-305. PubMed ID: 16266417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nudging or education to responsible choices? The example of breast screening].
    Tallacchini M
    Epidemiol Prev; 2017; 41(1):14-19. PubMed ID: 28322524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Including values in evidence-based policy making for breast screening: An empirically grounded tool to assist expert decision makers.
    Parker L
    Health Policy; 2017 Jul; 121(7):793-799. PubMed ID: 28571666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women's views on breast cancer risk and screening mammography: a qualitative interview study.
    Silverman E; Woloshin S; Schwartz LM; Byram SJ; Welch HG; Fischhoff B
    Med Decis Making; 2001; 21(3):231-40. PubMed ID: 11386630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women.
    Mathieu E; Barratt A; Davey HM; McGeechan K; Howard K; Houssami N
    Arch Intern Med; 2007 Oct; 167(19):2039-46. PubMed ID: 17954796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subject positions in screening mammography and implications for informed choice.
    Seaman K; Dzidic PL; Castell E; Saunders C; Breen LJ
    Psychol Health; 2021 Apr; 36(4):478-495. PubMed ID: 32404016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of clinical breast examination in cancer screening for women at average risk: A mini review.
    Brennan ME
    Maturitas; 2016 Oct; 92():61-63. PubMed ID: 27621240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.